Improved Anti-Tumor Efficacy via Combination of Oxaliplatin and Fibrin Glue in Colorectal Cancer

Oncotarget - United States
doi 10.18632/oncotarget.23507
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Overcomes Oxaliplatin Resistance and Promotes Anti-Tumor Immunity in Colorectal Cancer.

Cancer Research
Cancer ResearchOncology
2019English

Fibrin Glue in Neurosurgery

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
2017English

2363 Inducing Anti-Tumor Immunity in Colorectal Cancer

Journal of Clinical and Translational Science
Medicine
2018English

Efficacy and Safety of Oxaliplatin, Bevacizumab and Oral S-1 for Advanced Recurrent Colorectal Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Autologous Fibrin Glue: Synthesis and Application

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2003English

Comparison of Self-Made Cryopreservative Fibrin Glue and Commercial Fibrin Glue Kit in Pterygium Surgery: 1-Year Follow-Up

Acta Ophthalmologica
MedicineOphthalmology
2017English

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin Through Induction of Stem-Like Properties in Human Colorectal Cancer

Stem Cells International
Cell BiologyMolecular Biology
2015English

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy